Please assess the completion status of the following clinical trial:

Trial Title: Attenuation Corrected Cardiac SPECT Using the GE Hawkeye Camera System

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients referred to the Charlton Nuclear Cardiology Laboratory for stress Tc-99m sestamibi SPECT~Exclusion criteria:~* Prior PTCA or CABG~* Left bundle branch block (LBBB) or paced ventricular rhythm~* Clinically significant valvular heart disease~* Hypertrophic or idiopathic dilated cardiomyopathy~* Atrial fibrillation or frequent atrial or ventricular ectopy (defined as \>20% ectopic beats~* History of MI~* ECG evidence of MI~* Chest circumference \>55 inches

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Clinical SPECT (Type: ACTIVE_COMPARATOR): GE Hawkeye Attenuation Correction Camera is being compared to the approved clinical use SPECT camera.

Based on this trial design, predict the completion outcome and termination type (if applicable).